ARTICLE | Clinical News
Revlimid lenalidomide regulatory update
September 29, 2014 7:00 AM UTC
The U.K.'s NICE issued final guidance recommending Revlimid lenalidomide from Celgene to treat patients with transfusion-dependent anemia with low- or intermediate-1-risk myelodysplastic syndromes (MD...